Skip to content

BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay 441126Recalls & reported problems

Becton, Dickinson And Company · Kit CT Qx Amplified Dna Assay · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00382904411268), received between Jan 7, 2022 and Nov 6, 2023 — classified as 5 malfunctions.

The most frequently reported specific device problem is “False Negative Result” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 3 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520263
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • False Negative Result3
  • False Positive Result2

Patient problems

  • No Clinical Signs, Symptoms or Conditions5

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 6, 2023False Negative Result; False Negative Result

    2 OF 3: IT WAS REPORTED THAT WHILE CUSTOMER WAS PERFORMING CROSS-PLATFORM TESTING WITH XTR AND MAX USING BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK, PATIENT SAMPLE WAS DISCREPANT ON XTR ONLY. THE RESULTS HAVE NOT BEEN REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18072771 ↗
  • MalfunctionNov 6, 2023False Negative Result; False Negative Result

    3 OF 3: IT WAS REPORTED THAT WHILE CUSTOMER WAS PERFORMING CROSS-PLATFORM TESTING WITH XTR AND MAX USING BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK, PATIENT SAMPLE WAS DISCREPANT ON XTR ONLY. THE RESULTS HAVE NOT BEEN REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18072769 ↗
  • MalfunctionNov 3, 2023False Negative Result; False Negative Result

    1 OF 3: IT WAS REPORTED THAT WHILE CUSTOMER WAS PERFORMING CROSS-PLATFORM TESTING WITH XTR AND MAX USING BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK, PATIENT SAMPLE WAS DISCREPANT ON XTR ONLY. THE RESULTS HAVE NOT BEEN REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18066890 ↗
  • MalfunctionFeb 24, 2023False Positive Result; False Positive Result

    IT WAS REPORTED THAT BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK 1 PATIENT SAMPLE CAME BACK POSITIVE BUT WHEN RERUN TESTED NEGATIVE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: 1 PATIENT SAMPLE WAS AFFECTED; DR. REQUESTED A RERUN, THE SAMPLE WAS NEG, REPORTED AS NEG.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16436886 ↗
  • MalfunctionJan 7, 2022False Positive Result; False Positive Result

    IT WAS REPORTED THAT WHILE USE WITH THE BD PROBETEC¿ CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY REAGENT PACK, A (B)(6) RESULT WAS OBTAINED. REPEAT TESTING WAS PERFORMED, AND THE RESULTS WERE (B)(6). THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: POTENTIAL (B)(6). LAB RECEIVED SAMPLE FROM (B)(6) FOR (B)(6) TESTING, RAN ON VIPER AND REPORTED (B)(6) RESULT. PATIENT REFERRED TO (B)(6) CLINIC WHO TESTED AGAIN AND RESULTS CAME BACK (B)(6). LAB RE-TESTED THE ORIGINAL SAMPLES WHICH HAD BEEN STORED AND IT REPORTED A (B)(6) RESULT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13195064 ↗

Other DNA-REAGENTS, NEISSERIA devices

All DNA-REAGENTS, NEISSERIA devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page